Sign in
Taking people in United StatesNo phase

Collecting survey and health record information from people with Charcot-Marie-Tooth disease

Gathers survey answers and health records from people with Charcot-Marie-Tooth disease.

Key facts

Who runs it
Hereditary Neuropathy Foundation
Where
New York, United StatesSee the site
Trial code
Registry title
Natural History Study for Charcot Marie Tooth Disease
Status
Recruiting
People taking part
10,000 people, planned
Started
1 Nov 2013
Expected to end
31 Dec 2029
Type of study
Observational
Record updated
17 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children, adolescents and adults who have, or may have, Charcot-Marie-Tooth disease (CMT) or another inherited nerve disease. Participants fill in a survey about their disease.

Age
Children, adolescents and adults.
Sex
All sexes can join.
Disease stage
A confirmed or suspected diagnosis of CMT or another inherited neuropathy (nerve disease that runs in families). The diagnosis can come from family history, standard tests such as a nerve exam, EMG or NCS, or genetic testing.
Biomarker or test result
A genetic test is not required. Many gene changes have not been found yet.

Main reasons for not taking part

  • People who do not have Charcot-Marie-Tooth or another inherited neuropathy cannot join.

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patients will be made aware of the study by HNF and others (referenced above) and invited to participate. Once patients have reviewed and signed electronically the informed consent document, it is attached to their file
  • All affected individuals with CMT/IN are eligible to participate in GRIN with proper informed consent
  • Children, adolescents and adults with either a confirmed diagnosis or suspected to have CMT/IN are eligible with parent and/or guardian consent
  • Individuals that have been clinically diagnosed through family history and/or standard clinical testing (e.g. neuro exam, EMG, NCS) and/or genetically tested or suspected to have CMT/IN (note: many mutations have not been identified yet) are eligible

Who cannot take part

  • People that do not have Charcot-Marie-Tooth or other Inherited Neuropathies

Where in United States

  • Hereditary Neuropathy FoundationNew York, United StatesContact: Allison MooreTaking people

About the trial

What the trial wants to find out

The goal of this Natural History Study for Charcot-Marie-Tooth is to acquire, record, and analyze patient-reported data and associated genetic reports, Electronic Health Records (EHRs) and clinical notes to identify the burden, diagnostic journey, and prevalence of disease that will aid scientists in their work toward finding a cure.

Read full original descriptionShow less

Participants will be asked to complete a Natural History Survey.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Global Registry for Inherited Neuropathies Natural History Study for Charcot Marie Tooth Disease
Plain-language title
Collecting survey and health record information from people with Charcot-Marie-Tooth diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
17 September 2026